By Ahmed Aboulenein and Maggie Fick WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald ...

President Donald Trump announced on Monday that British-Swedish drugmaker AstraZeneca will be investing $50 billion in the ...

The move is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry. Read more at ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

British-based drug maker AstraZeneca has announced plans to invest $50 billion in the United States over the next five years ...

AstraZeneca unveils plans for £37bn investment in US amid tariff threats - US President Donald Trump has threatened to impose ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

American President Donald Trump is pressuring the pharma industry with tariffs, from which Swiss manufacturers might be ...

Markets reflect a widespread belief that the US president always chickens out on trade measures. AstraZeneca’s plan to invest ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

CANBERRA, July 9 (Xinhua) -- The Australian government is very concerned about U.S. threats to impose increased tariffs on pharmaceutical and copper imports, Treasurer Jim Chalmers said on Wednesday.